Erythromycin is a macrolide antibiotic used to treat various bacterial infections, including respiratory tract infections and skin infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth. It is grouped under the following drug class(es): Macrolides and QTc-prolonging agents. Its therapeutic use is listed as acne agents, anti-infectives, antibacterials, antibiotics and dermatologicals. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Erythrocin, Ery-Tab, E-Mycin and Abomacetin. Its PubChem CID is 12560.
Erythromycin
| CAS No | 114-07-8 |
|---|---|
| Molecular Formula | C37H67NO13 |
| Molecular Weight | 733.9 g/mol |
| Synonyms | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin is a macrolide antibiotic used to treat various bacterial infections, including respiratory tract infections and skin infections. It works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth.
The listed CAS number is 114-07-8.
The listed molecular formula is C37H67NO13.
The listed molecular weight is 733.9 g/mol.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione.
The source lists Erythrocin, Ery-Tab, E-Mycin and Abomacetin.